PD_{n-3 DPA} Pathway Regulates Human Monocyte Differentiation and Macrophage Function.

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• Macrophages are crucial for clearing cellular debris during inflammation.
• The precise mechanisms governing macrophage-mediated clearance are not fully understood.
• Lipid mediators play significant roles in inflammatory and resolution processes.

Purpose of the Study:

• To elucidate the biosynthetic pathway of n-3 docosapentaenoic acid-derived protectin (PDn-3 DPA) in human monocytes and macrophages.
• To investigate the role of this pathway in regulating macrophage phenotype and function.
• To identify the key enzymes and intermediates involved in PDn-3 DPA synthesis.

Main Methods:

• Lipid mediator profiling of human primary cells.
• Enzymatic assays using recombinant human 15-lipoxygenases and epoxide hydrolases.
• Stereocontrolled total organic synthesis to determine epoxide stereochemistry.
• Analysis of macrophage differentiation, efferocytosis, and bacterial phagocytosis.

Main Results:

• The PDn-3 DPA pathway is initiated by human 15-lipoxygenases, forming a specific epoxide intermediate (16S,17S-ePDn-3 DPA).
• Epoxide hydrolases, particularly epoxide hydrolase 2, convert this intermediate to PD1n-3 DPA and PD2n-3 DPA in human monocytes.
• Activation of the PDn-3 DPA pathway altered macrophage phenotype, enhancing efferocytosis and bacterial phagocytosis.

Conclusions:

• The PDn-3 DPA biosynthetic pathway is established in human monocytes and macrophages.
• This pathway plays a critical role in regulating macrophage-mediated resolution of inflammation.
• PDn-3 DPA represents a novel class of lipid mediators involved in immune homeostasis.